Global Update (non-endemic countries): As of 30 August 2022, 49,974 confirmed cases of monkeypox and 110 deaths were reported from 99 countries/territories globally. The countries reporting the majority of cases are mainly in Europe and North America.
Africa update (endemic and non-endemic countries): Since the last brief (24 August 2022), 98 new cases (24 confirmed; 74 suspected) and two new deaths (CFR:2%) of monkeypox were reported from Morocco, Nigeria and South Africa. This is a 50% decrease in the number of new confirmed cases since the last brief. Cumulatively, 3,549 cases (483 confirmed; 3,066 suspected) and 107 deaths (case fatality rate [CFR]: 3%) of monkeypox were reported from 11 African Union (AU) Member States (MS) since January 2022 (Table 1).
Morocco: Since the last brief (2 June 2022), the Morocco MoH reported two new confirmed cases and no deaths of monkeypox. This is a 100% increase in the number of confirmed cases compared to the previous brief. Cumulatively, three confirmed cases of monkeypox were reported from Morocco in 2022. All confirmed cases reported a travel history to Europe.
Nigeria: Since the last brief (26 August 2022), the Nigeria Centre for Disease Control (NCDC) reported 95 new cases (21 confirmed; 74 suspected) and two new deaths (CFR:2.1%) of monkeypox in Nigeria. This is a 56% decrease in the number of new confirmed cases compared to the last report. Cumulatively, 845 cases (241 confirmed; 604 suspected) and six deaths (CFR: 1%) of monkeypox were reported from 34 states and the federal capital territory.
South Africa: Since the last brief (17 August 2022), one confirmed case and no new deaths of monkeypox were reported in South Africa. The confirmed case is a 28-year-old male from Johannesburg in Gauteng province with a recent travel history to the Netherlands/Spain. Cumulatively, five confirmed cases and no deaths were reported from three provinces: Gauteng (2 cases), Limpopo (1) and Western Cape (2).